Reply to "Mitochondrial DNA deletions discriminate affected from unaffected LRRK2 mutation carriers"

Ann Neurol. 2019 Aug;86(2):326-327. doi: 10.1002/ana.25509. Epub 2019 Jun 12.

Authors

Rachit Bakshi^{1

2}, Eric A Macklin^{2

3}, Michael A Schwarzschild^{1

2}

Affiliations

¹ Department of Neurology, Massachusetts General Hospital, Boston, MA.
² Harvard Medical School, Boston, MA.
³ Biostatistics Center, Department of Medicine, Massachusetts General Hospital, Boston, MA.

PMID: 31148194
DOI: 10.1002/ana.25509

No abstract available

Publication types

Letter
Comment

MeSH terms

DNA, Mitochondrial
Humans
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
Mutation
Parkinson Disease*
Protein Serine-Threonine Kinases / genetics
Uric Acid

Substances

DNA, Mitochondrial
Uric Acid
LRRK2 protein, human
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
Protein Serine-Threonine Kinases